chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced what felt like an electric headache that lasted four days, chills, flu-like cold symptoms, congestion, and shortness of breath. Today is day six, and I am still under the weather.
Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 02Apr2021 at 18:30 (at the age of 60-old-years) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (MANUFACTURER UNKNOWN) and atorvastatin calcium (MANUFACTURER UNKNOWN); both for unspecified indication and start date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 12Mar2021 at 19:30 (at the age of 60-old-years) as a single dose for COVID-19 immunisation. The patient did not have any allergies to any medications, food, or other products. On 02Apr2021, the patient experienced tinnitus. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
lt thigh red, hot 4cm diameter;may use APAP, Ibuprofen, DPH & cold compresses PRN;
I got the H1N1 shot at 11:20 AM, Dec. 4, 2009 an I got home around 2:45 PM.  Could hardly walk - I was stiff in hip area.  Could not lay on my side it hurt so bad.  Sat morning still slow moving - Monday some pain but not like on Friday. Took tylenol which helped a bit.
terrible hives mostly from waist up soon even feet and hands / milder, smaller patches; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (terrible hives mostly from waist up soon even feet and hands / milder, smaller patches) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Mar-2023, the patient experienced URTICARIA (terrible hives mostly from waist up soon even feet and hands / milder, smaller patches). At the time of the report, URTICARIA (terrible hives mostly from waist up soon even feet and hands / milder, smaller patches) was resolving.            No concomitant products reported.  It was reported that patient got the new booster on March 2nd. Ten days later, started having terrible hives mostly from waist up, soon even feet and hands. Patient was about to start sixth week with the problem. patient questioned was there any antidote and how long it was going to last for. The only good news was that the last 2 weeks it had been milder, smaller patches and less time. Patient went from 2 hours at a time to about 20 minutes.  No treatment products reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2023: Non Significant follow up appended
Half dollar size knot with rash down my arm. Painful to raise my arm. Took 2 Benadryl  saturday afternoon and 2 at night before bed ,by morning the knot was pea size and rash was gone
Pfizer Covid-19 vaccine administered on 04/06/2022 date has been determined to be outside of the recommended stability guidelines by Pfizer and the CDC and a repeat dose is recommended.
on the evening of 1/10/2020, patient had (10) episodes of shuttering/shivering. Happened even during play. No LOC. Episodes last for seconds - Does not turn blue. Seen in the ER locally on 1-11-20 and sent to ER for evaluation and admission
upper lip tingling, tongue, no SOB, palpitations, edema 12:03 25mg Benadryl given 12:12 numbness subsided 12:24 asymptomatic Walked around for approximately 5 minutes. Denied sleepiness and stated "I am fine to drive"
I had a breakthrough case of Covid. I had a dull headache for a couple of days then had fatigue, fever, aches and pains, no energy whatsoever, slept a lot, felt truly awful, took PAXLOVID. Not sure it helped much.
Presented with SOB, fever, body aches, chest pain, cough x 5 days; dx Covid + 5 days PTA; dx Covid PNA; treated with Vit, C,D, Dexamethasone, Zinc, O2, bronchodilators, minimal supplemental O2; discharged home on room air
Chills; swollen lymph node in armpit; still painfull; Vaccination site swelling; Vaccination site redness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    A spontaneous report  was received from a health care professional concerning a 68-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed serious chills and a swollen lymph node in the armpit Redness and swelling at the vaccination site..       The patient's medical history was reported  that she is cancer survivor and had undergone mastectomy 2.5 years ago.. Products known to have been used by the patient, within two weeks prior to the event, was not reported.     On 18 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot 011L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 16 Feb 2021, prior to the onset of the event, the patient received their second of two planned doses of mRNA-1273 (Lot 031M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 19 Jan 2021, the patient developed vaccination site redness and swelling .  Treatment for the event was not reported. On 16 Jan 2021 ,the patient developed severe chills, swollen lymph node in the armpit and pain .Treatment for event was not reported.     Action taken with mRNA-1273 in response to the event was not reported.      The outcome of the event, vaccination site redness and swelling, severe chills, swollen lymph node in the armpit  , was considered recovering/resolving.  The outcome of the event, Pain, not recovered.
When she is itching, her body begins to bleed; When she is itching, her body begins to bleed; Took the booster about 1 month ago and she is still having side effects; This spontaneous case was reported by a consumer and describes the occurrence of HAEMORRHAGE (When she is itching, her body begins to bleed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced HAEMORRHAGE (When she is itching, her body begins to bleed) (seriousness criterion medically significant), PRURITUS (When she is itching, her body begins to bleed) and VACCINATION COMPLICATION (Took the booster about 1 month ago and she is still having side effects). At the time of the report, HAEMORRHAGE (When she is itching, her body begins to bleed), PRURITUS (When she is itching, her body begins to bleed) and VACCINATION COMPLICATION (Took the booster about 1 month ago and she is still having side effects) had not resolved.            Concomitant products were not provided. Treatment medications were not reported.  Company Comment : This spontaneous case concerns a female patient with unknown age , with no medical history reported , vaccinated for two doses , primary series using mRNA-1273 vaccine ,  who experienced Serious ( Medically significant ) , unexpected event of hemorrhage and other non-serious, unexpected events of pruritus and vaccination complication. These events occurred on Dec. 2021 after vaccination with the 3rd dose of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . The re-challenge for this case is not applicable since the events had not resolved and the events occurred after the 3rd dose and no additional doses will be given. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient with unknown age , with no medical history reported , vaccinated for two doses , primary series using mRNA-1273 vaccine ,  who experienced Serious ( Medically significant ) , unexpected event of hemorrhage and other non-serious, unexpected events of pruritus and vaccination complication. These events occurred on Dec. 2021 after vaccination with the 3rd dose of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . The re-challenge for this case is not applicable since the events had not resolved and the events occurred after the 3rd dose and no additional doses will be given. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.
Ever since I have had the vaccine, my menstrual cycle has been very heavy with several blood clots. Every cycle has included this heavy flow and blood clotting  since the vaccine.
"minor soreness".Reporter was made aware of the adverse event at 6:18 on 19 April 2021.; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administration date 17Apr2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number:Not Reported), administration date: Mar2021, for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 17Apr2021 06:18, outcome "recovered" (Apr2021), described as ""minor soreness".Reporter was made aware of the adverse event at 6:18 on 19 April 2021.". Therapeutic measures were not taken as a result of pain.  Additional information: The patient was not diagnosed with COVID-19 prior to vaccination. It was unknown that patient receive any other vaccines within 4 weeks prior to the COVID vaccine and the patient been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report has been received from a physician referring to a 25 year old female patient. The patient did not have pertinent medical history, drug reactions or allergies, concurrent conditions or concomitant medications. On 04-JAN-2018, the patient was vaccinated with the first dose of GARDASIL 9 lot # N026812, expiration date 22-JUN-2017, by intramuscular route for prophylaxis. After vaccination while leaving the physician's office, the patient experienced headache, nausea, stomach pain, diarrhea and felt light headed (dizziness and abdominal pain upper). On 05-JAN-2018, the patient explained to the physician that the adverse effects had resolved, without receiving treatment within 24 hours. The patient sought for medical attention however none laboratory studies were performed. The causality assessment between therapy with GARDASIL 9 and the events was not reported.
I experienced joint pain and was extremely stiff (hard to move my arms and legs). My right shoulder froze up and my doctor sent me to a specialist who ordered physical therapy to get it to break free within the 1st month after taking the vaccine. The following month my left shoulder did the same thing (still frozen) and then I tore the Achilles tendon in my right knee that is really bad. When I push on my right calf, the dent doesn't go away for the last 4 to 5 weeks. I have been to the ER, Urgent Care, and other Doctors who are still working with me to find out the cause of my symptoms. I was really healthy before the 2nd dosage of the vaccine but it has steadily declined since then.
Td given 6-11-08 following turtle bite same day - called next AM and states she vomited several times during noc, had fever and ached all over. Adv. to see NP. declined but still complained of aching and vom on 6-17 so saw Dr. who told her it was a reaction to Td - Next day NP, called her to tell her she had kidney inf - Several days later was adm to hosp - had had antibiotic - all test were neg - endoscopy done to determine if client had ulcer - Results unk. 8/4/08-records received for DOS 6/30-7/2/08- DX: Abdominal pain with diarrhea. Abdominal pain may be secondary to peptic ulcer disease, rule out pancreatitis.  Dehyration. C/O generalized abdominal pain in mid epigastric area with vomiting since 6/11/08. Few bout of diarrhea.
Pt state the he rec'd the vaccine during an office visit on 3/4/19. Pt states that on 3/5/19 his noted moderate RUE tenderness. On 3/6/19 RUE pain had worsened and pt noted reddened and blue skin discoloration on his right deltoid. Pt woke up today and report that the RUE pain was so severe that he cannot use his R arm at all and that the skin discoloration is spreading towards his chest.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age with skin cancers. On 05-NOV-2014 the patient was vaccinated with ZOSTAVAX (0.65 ml, subcutaneous, lot# was not reported). The pharmacist reported that patient had an unspecified blue light facial treatment on 10-NOV-2014 for skin cancers that developed on an unspecified date prior to receiving the ZOSTAVAX. He stated that the patient developed redness on her face after receiving the facial treatment that had gradually gotten worse since 10-NOV-2014. He reported that the patient was seen by her physician on an unknown date and the patient's physician prescribed her prednisone 20mg daily for seven days. No lab was performed. The outcome of redness on her face was reported as not recovered/not resolved. Additional information has been requested.
THE EVENING AFTER THE SHOT WAS ADMINISTERED THE CLIENT REPORTS SLIGHT SWELLING AND REDNESS AT THE INJECTION SITE. TODAY 12/02/2009 THE RD IS SWOLLEN, RED, AND WARM TO TOUCH. NO FEVER REPORTED. PER CLIENT SHE CANNOT TAKE OTC PAIN MED/ANTI-INFLAMMATORY DUE TO LIVER PROBLEMS. SHE WENT TO THE ER TODAY, BUT THEY REFERRED HER BACK TO THE HEALTH DEPARTMENT. CLIENT ADVISED TO APPLY COLD COMPRESSES TO INJECTION SITE AND APPLY BENADRYL CREAM TO AREA. TO CALL PRIVATE MD TO DETERMINE IF BENADRYL CAN BE TAKEN PO. IF ARM IS WORSE OR SHOWS NO IMPROVEMENT ON 12-03-2009, SHE IS TO GO TO HER PRIVATE PROVIDER. SHE REPORTED LATE AFTER ON 12-02-2009 OF REACTION (4:00 P.M.).
This is a spontaneous report from a contactable consumer, reporting for her daughter. A 17 year-old Other ethnic group female patient received the first single dose of TRUMENBA intramuscular in Jun2016 (unknown if on 13Jun2016 or 14Jun2016) at 10:15 am intramuscular in the left upper arm. The patient had ongoing drug hypersensitivity to MOTRIN emerged when she was 11 year-old and after having taken it for toothache she had itchy mouth and lips became swollen. The patient was not taking any concomitant medication. No other vaccines were administered the same day or within four weeks prior to TRUMENBA. It was reported that at first TRUMENBA really hurt when it was administered and the pain in the patient's arm took about 4 days to completely go away. Then about 40 to 45 minutes after she had received the vaccine she became very pale, which lasted about 1 1/2 hours and complained of headaches, which lasted about 1 1/2 days. She also felt as though she was going to pass out, was nauseated, and had shaking chills, which just lasted that day. When the mother got her daughter home she gave her BENADRYL and continued to check on her every few minutes. A few hours after vaccination she checked her blood pressure and heart rate and noticed that they were respectively elevated and fast, but they were back to normal the next day. She noticed that her daughter's lips looked swollen, but that went away by the next day. Her daughter also complained of feeling very tired and slept on and off for about 12 hours. The next day her daughter complained of a sore throat and having a hard time swallowing. The sore throat and hard time swallowing lasted about 2 days. The caller reported that she had experienced anaphylaxis in the past and that was how it started, so she thought that her daughter was allergic to TRUMENBA. No relevant tests were performed, no physician or emergency room visit were needed. Follow-up (12AUG2016): Follow-up attempts are completed. No further information is expected.
Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 12/17/2022 Discharge Date: 12/19/2022 COVID positive 12/17/2022 HOSPITAL COURSE: Patient is a 76-year-old female with history of moderate persistent asthma, GERD, OSA, anxiety and recent TIA who presented with increased weakness, congestion, cough and sneezing.  In the ED, she tested positive for COVID-19.  She was tachycardic, but otherwise hemodynamically stable.  Chest x-ray was negative for pneumonia.  Labs showed sodium 129, chloride 95.  She was placed on observation for generalized weakness and hyponatremia related to COVID-19.   Upon admission, she was placed on IV fluids.  With hydration, her sodium and chloride normalized.  Remainder of labs and vital signs remained stable.  She was seen by PT and OT, who felt that she was safe to return home.  Her respiratory status remained stable on room air, and she did not qualify for advanced therapies for COVID-19, including Decadron or Remdesivir.   She was felt stable for discharge home on 12/19/22.  She should follow-up with her PCP in 1 week.  She will be followed by the COVID-at-home program at discharge.
allergic reaction; screamed; This case was reported by a consumer via interactive digital media and described the occurrence of drug allergy in a female patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced drug allergy and screaming. On an unknown date, the outcome of the drug allergy was unknown and the outcome of the screaming was recovered/resolved.   It was unknown if the reporter considered the drug allergy and screaming to be related to DTPa vaccine.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination the patient had screaming for 12 days and was allergic to whooping cough vaccine. The patient reported that, it was accumulative so the fourth or fifth would have killed her and it was P in DTP. The reporter stated that, the doctor said nothing. The patient's sister in law warned that her daughter reacted.
8x8cm red slightly tender area around the left leg. Patient advise to use Benadryl.
I did not have an adverse reaction to the vaccine but contracted Covid in May. I was Covid positive in January 2021 too. Took Bamlanivimab for Covid in January and I took Bebtelovimab in May. They both worked really well. Scratching throat, the sore throat got worse, I had stuffy nose, nausea, fatigue and body aches in both cases.
Secondary Transmission Nonvaccinee Limited details - Primary vaccinee had been vaccinated in early February 2003 and had contact with his 23-y.o. spouse. Approximately 2 weeks after his vaccination, she developed a lesion that initially resembled a spider bite and was described as edematous, erythematous and not much exudate (not sure of location of lesion). Contact had history of acne.
Given adult dose from private stock. No reaction noted with observation by physician and parent. Parents informed of error.
9/20/21, I had sharp chest pain intermittently for 3 days. I did not seek care until 11/1/21 when the chest pain became severe with shortness of breath. Initially I was prescribed antibiotics for presumed respiratory infection. On 11/3/21 I went to Hospital for evaluation and was diagnosed with cardiac tamponade due to pericarditis. I had to have a cardiothoracic surgeon perform a pericardial window and remained hospitalized until 11/7/21.
Chest pains; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pains). At the time of the report, CHEST PAIN (Chest pains) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
Severe nosebleed occurred on 04/19/21 at 10:05. I was at work, sitting down in my office. Nose was not aggravated by any means (picking, blowing...). I was admitted to emergency room. I was bleeding for 4 hours before ER doctors managed to stop the bleed (I was told that routine procedure was used to stop the bleed). The less severe nosebleed occurred on 04/21/21 with another visit to ER. It was early morning and I was at home getting ready for work. Bleeding was less severe and it was stopped after approximately 1 hour.  I am not prone to nosebleeds and this was highly unusual occurrence. I did not change my exercise, sleeping, dietary or medicine taking routine in years.
Sore arm at location of shot. Feels like bruised and slightly inflamed. Pain Slowly starting to dissipate. Still feel discomfort at the date of this submission (4days after shot)
LD, redness area, itching present, no open areas, swelling present, diphenhydramine 1% topical cream.
Corrected copy for previous form as it was a Twinrix #2 rather than Hep B #2 administered on 4/16/08.  One hour afterward, throat became dry and arms became red.  On 17th, arms became itchy and she felt like she was on fire all over.  Also felt like she was going to pass out.  Stated eyes were swollen.
4/15 I went to ER with upper respiratory issues. Was diagnosed with bacterial upper respiratory infection. During the ER visit elevated liver enzymes were and I was referred to my PCP. PCP has noticed an upward trend in liver enzymes and ordered an ultrasound. Ultrasound report indicated a polyp on gall bladder and fatty liver. PCP referred me to gastroenterologist and I am currently awaiting that appointment.
This case described the occurrence of "arthritis feelings" in the fingers of an adult female patient who received Lyme disease vaccine recombinant OspA (LYMErix) for prophylaxis. This report was received from a patient, who is a pharmacist. On a unspecified date, the patient received her 3rd dose of LYMErix. "A few months" later, the patient began to experience "arthritis feelings" in her fingers. As of 25 June 2003, the event persisted.
pt recv vax 15MAY98 & devel local body urticaria;mom brought to clinic on 18MAY98-urticaria still present-tested + for strep;recheck 20MAY98 leg weakness-referred to MD dx w/probable GBS;when pt seen in clinic 18MAY had chickenpox;